Remove clinical-role specialty-pharmacy
article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

Since buying the chain, Amazon has made strategic expansions of its brick-and-mortar locations ( Connecticut , San Francisco , and Milwaukee ), increased IDN partnerships for specialty referrals to 18, and introduced healthcare-focused subscription services, including One Medical and RxPass.

Retail 52
article thumbnail

What Is A Diabetes Sales Specialist? With O’Neal Ford

Evolve Your Success

Dive into the role of a Diabetes Sales Specialist and explore the diverse opportunities that await. In this episode for Black History Month, Samuel Adeyinka interviews District Sales Trainer & Diabetes Sales Specialist, O’Neal Ford , to shed light on his role. Give us a little bit more understanding about that role.

Sales 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Market Access Veteran Ellen Cappellino Joins Klick Health

PM360

As Executive Director Value, Access, and Reimbursement, Cappellino is working cross-functionally, harnessing Klick’s industry-leading clinical, creative, and analytics, to demonstrate the benefits and optimal places in treatment for therapies.

article thumbnail

Povorcitinib by Incyte for Hidradenitis Suppurativa: Likelihood of Approval

Pharmaceutical Technology

Povorcitinib is under clinical development by Incyte and currently in Phase III for Hidradenitis Suppurativa. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

article thumbnail

Orvacabtagene autoleucel by Bristol-Myers Squibb for Relapsed Multiple Myeloma: Likelihood of Approval

Pharmaceutical Technology

Orvacabtagene autoleucel is under clinical development by Bristol-Myers Squibb and currently in Phase II for Relapsed Multiple Myeloma. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. BMS provides its products in the US, Europe, and Japan.

Retail 40
article thumbnail

Danicamtiv, what is the likelihood that the drug will be approved?

Pharmaceutical Technology

Danicamtiv is under clinical development by Bristol-Myers Squibb and currently in the Phase I and Phase II in clinical pathway. The company offers its products across the world to wholesalers, retail pharmacies, hospitals, medical professionals and government entities. BMS provides its products in the US, Europe, and Japan.

Retail 40
article thumbnail

The Second Order Effects of the Inflation Reduction Act: What Uncertainties Does Pharma Need to Plan For?

PM360

It seems likely that evidence demonstrating clinical advantages compared to directly competing therapies or cost savings compared to competing treatments will likely be considered. specialty pharmacies, Group Purchasing Organizations or GPOs, in-office dispensing clinics).